Abstract:
In some examples, a leadless pacing device (hereinafter, “LPD”) is configured for implantation in a ventricle of a heart of a patient, and is configured to switch between an atrio-ventricular synchronous pacing mode and an asynchronous ventricular pacing mode in response to detection of one or more sensing events, which may be, for example, undersensing events. In some examples, an LPD is configured to switch from a sensing without pacing mode to an atrio-ventricular synchronous pacing mode in response to determining, for a threshold number of cardiac cycles, a ventricular depolarization was not detected within a ventricular event detection window that begins at an atrial activation event.
Abstract:
An intracardiac pacemaker is configured to filter a raw cardiac electrical signal received by the pacemaker to produce a filtered cardiac electrical signal, analyzes the filtered cardiac electrical signal to establish cardiac event sensing criteria that discriminate P-waves from T-waves and R-waves all present in the raw cardiac electrical signal, and sense the P-waves from the filtered cardiac electrical signal when the established cardiac event sensing criteria are met. Sensed P-waves may be used for controlling atrial-synchronized ventricular pacing delivered by the pacemaker.
Abstract:
A method and apparatus for identifying loss of capture in a pacing device. While pacing pulses are being delivered, the device checks for emergence of a stable asynchronous underlying intrinsic rhythm in the presence of the delivered pacing pulses. The device determines that loss of capture has occurred responsive to emergence of the underlying rhythm. In response to determining that loss of capture has occurred, pacing provided by device is modified, for example by performing a threshold test and adjusting the energy levels of delivered pacing pulses in response thereto.
Abstract:
A device includes a signal generator module, a processing module, and a housing. The signal generator module is configured to deliver pacing pulses to an atrium. The processing module is configured to detect a ventricular activation event and determine a length of an interval between the ventricular activation event and a previous atrial event that preceded the ventricular activation event. The processing module is further configured to schedule a time at which to deliver a pacing pulse to the atrium based on the length of the interval and control the signal generator module to deliver the pacing pulse at the scheduled time. The housing is configured for implantation within the atrium. The housing encloses the stimulation generator and the processing module.
Abstract:
A medical device performs a method for computing an estimate of a physiological variable. The method includes sensing a physiological signal and measuring an event of the physiological signal. The device initializes a value of a long-term metric of the event measurement, wherein the long-term metric corresponds to a time interval correlated to a response time of the physiological variable to changes in the event. The estimate of the long-term metric is updated in a memory of the medical device using a previous long-term metric and a current measurement of the event. The device detects a need for computing the physiological variable and computes an estimate of the physiological variable using the updated long-term metric.
Abstract:
An intracardiac ventricular pacemaker having a motion sensor, a pulse generator and a control circuit coupled to the pulse generator and the motion sensor is configured to identify a ventricular systolic event, detect a ventricular passive filling event signal from the motion signal, and determine a time interval from the ventricular systolic event to the ventricular passive filling event. The pacemaker establishes a minimum pacing interval based on the time interval.
Abstract:
An intracardiac ventricular pacemaker is configured to detect a ventricular diastolic event from a motion signal received by a pacemaker control circuit from a motion sensor. The control circuit starts an atrial refractory period having an expiration time set based on a time of the detection of the ventricular diastolic event. The control circuit detects an atrial systolic event from the motion signal after expiration of the atrial refractory period and controls a pulse generator of the pacemaker to deliver a pacing pulse to a ventricle of a patient's heart at a first atrioventricular pacing time interval after the atrial systolic event detection.
Abstract:
An intracardiac ventricular pacemaker having a motion sensor is configured to produce a motion signal including an atrial systolic event and a ventricular diastolic event indicating a passive ventricular filling phase, set a detection threshold to a first amplitude during an expected time interval of the ventricular diastolic event and to a second amplitude lower than the first amplitude after an expected time interval of the ventricular diastolic event. The pacemaker is configured to detect the atrial systolic event in response to the motion signal crossing the detection threshold and set an atrioventricular pacing interval in response to detecting the atrial systolic event.
Abstract:
A method uses internal patient data from an implantable medical device (IMD) and environmental factor information associated with cardiovascular diseases as input to a predictive cardiovascular disease software tool for enabling alerts, e.g., generated by a computing system configured to receive data from the IMD. A computing system may receive diagnostic metric data from the IMID and time correlated location data of the patient, e.g., from a smartphone, smartwatch, or other computing device of the user. The computing system may use the patient's location, such as from a user's device such a programmer or patient's computing device, to determine a particulate matter exposure level corresponding to the diagnostic metric data that may then be used as an input to a predictive cardiovascular disease software tool to refine the risk score or risk stratification.
Abstract:
Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia. The LPD may receive communication from the SICD requesting the LPD deliver anti-tachycardia pacing to the heart and determine, based on a second electrical signal from the heart sensed by the LPD, whether to deliver anti-tachycardia pacing (ATP) to the heart. In this manner, the SICD and LPD may communicate to coordinate ATP and/or cardioversion/defibrillation therapy. In another example, the LPD may be configured to deliver post-shock pacing after detecting delivery of anti-tachyarrhythmia shock therapy.